tiprankstipranks
Advertisement
Advertisement

TXMD Stock Latest News

TherapeuticsMD reports Q1 EPS 1c vs. (6c) last year
The FlyTherapeuticsMD reports Q1 EPS 1c vs. (6c) last year
22d ago
TXMD
TherapeuticsMD Reports Quarterly Profit, Evaluates Strategic Alternatives
PremiumCompany Announcements
TherapeuticsMD Reports Quarterly Profit, Evaluates Strategic Alternatives
22d ago
8K
TXMD
TherapeuticsMD Explains Brief Delay In Annual Filing
PremiumCompany Announcements
TherapeuticsMD Explains Brief Delay In Annual Filing
2M ago
TXMD
TherapeuticsMD Narrows 2025 Loss, Advances Royalty Strategy
PremiumCompany Announcements
TherapeuticsMD Narrows 2025 Loss, Advances Royalty Strategy
2M ago
8K
TXMD
TherapeuticsMD reports FY25 EPS (6c) vs. (20c) last year
PremiumThe Fly
TherapeuticsMD reports FY25 EPS (6c) vs. (20c) last year
2M ago
TXMD
TherapeuticsMD Approves Key Proposals at Annual Meeting
PremiumCompany AnnouncementsTherapeuticsMD Approves Key Proposals at Annual Meeting
6M ago
8K
TXMD
TherapeuticsMD Reports Q3 2025 Financial Results
Premium
Company Announcements
TherapeuticsMD Reports Q3 2025 Financial Results
7M ago
8K
TXMD
TherapeuticsMD reports Q3 EPS 0c vs. (5c) last year
Premium
The Fly
TherapeuticsMD reports Q3 EPS 0c vs. (5c) last year
7M ago
TXMD
TherapeuticsMD Reports Improved Q2 2025 Results
PremiumCompany Announcements
TherapeuticsMD Reports Improved Q2 2025 Results
10M ago
TXMD
TherapeuticsMD Reports Q2 2025 Financial Results
PremiumCompany Announcements
TherapeuticsMD Reports Q2 2025 Financial Results
10M ago
8K
TXMD
TherapeuticsMD reports Q2 EPS 5c vs. (9c) last year
PremiumThe Fly
TherapeuticsMD reports Q2 EPS 5c vs. (9c) last year
10M ago
TXMD
TherapeuticsMD Reports Improved Q1 2025 Results
PremiumCompany Announcements
TherapeuticsMD Reports Improved Q1 2025 Results
1y ago
TXMD
TherapeuticsMD Reports Q1 2025 Financial Results
PremiumCompany AnnouncementsTherapeuticsMD Reports Q1 2025 Financial Results
1y ago
8K
TXMD
TherapeuticsMD reports Q1 EPS (6c) vs. (7c) last year
Premium
The Fly
TherapeuticsMD reports Q1 EPS (6c) vs. (7c) last year
1y ago
TXMD
TherapeuticsMD Reports Improved Financial Performance
Premium
Company Announcements
TherapeuticsMD Reports Improved Financial Performance
1y ago
TXMD
TherapeuticsMD Reports Reduced Losses and Revenue Growth
PremiumCompany Announcements
TherapeuticsMD Reports Reduced Losses and Revenue Growth
1y ago
8K
TXMD
TherapeuticsMD Reports Reduced Losses Amid Strategic Shift
PremiumCompany Announcements
TherapeuticsMD Reports Reduced Losses Amid Strategic Shift
2y ago
TXMD
TherapeuticsMD Shifts Focus with Lower Q3 Losses
PremiumCompany Announcements
TherapeuticsMD Shifts Focus with Lower Q3 Losses
2y ago
8K
TXMD
TherapeuticsMD Releases Preliminary Quarterly Financial Results
PremiumCompany Announcements
TherapeuticsMD Releases Preliminary Quarterly Financial Results
2y ago
8K
TXMD
TherapeuticsMD Releases Preliminary Q1 2024 Financials
PremiumCompany AnnouncementsTherapeuticsMD Releases Preliminary Q1 2024 Financials
2y ago
8K
TXMD
TherapeuticsMD reports Q1 EPS (7c) vs (24c) last year
Premium
The Fly
TherapeuticsMD reports Q1 EPS (7c) vs (24c) last year
2y ago
TXMD
TherapeuticsMD Announces 2023 Annual Financial Results
Premium
Company Announcements
TherapeuticsMD Announces 2023 Annual Financial Results
2y ago
8K
TXMD

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >